A statement of changes in beneficial ownership was filed on September 2, 2026, by John Jiong Wu, a director of H World Group Ltd, disclosing the disposal of 9,784,090 ordinary shares at a price of $4.639 per share.
A Form 4 filed with the SEC on September 2, 2026 discloses that Kevin S. Blair, Chief Executive Officer and Director of Pinnacle Financial Partners, Inc. (NYSE:PNFP), purchased 2,565 shares of common stock on September 1, 2026.
A statement of changes in beneficial ownership was filed on September 2, 2026, by Diarmuid B. O'Connell, a director of Dana Inc, disclosing the accrual of dividend equivalent rights tied to previously granted restricted stock units.
Director Hanna Olivia Nelligan filed a Form 4 with the SEC on September 2, 2026, disclosing the acquisition of dividend equivalent rights tied to previously granted restricted stock units in Dana Inc (NYSE:DAN).
Brian Keith Pour, Senior Vice President and President of Commercial Vehicle Driveline at Dana Inc (NYSE:DAN), filed a statement of changes in beneficial ownership on September 2, 2026, reporting the accrual of 275 dividend equivalent rights on August 28, 2026.
Skyworks Solutions, Inc. filed a current report on September 2, 2026, disclosing that it has extended the expiration date of its exchange offers for outstanding senior notes originally issued by Qorvo, Inc., moving the deadline from September 1, 2026 to September 11, 2026.
Donegal Mutual Insurance Co filed a Form 4 with the SEC on September 2, 2026, disclosing two open-market purchases of Donegal Group Inc (NASDAQ:DGICA) Class A Common Stock on August 31 and September 1, 2026.
News Corporation filed a Form 8-K with the SEC on September 2, 2026, reporting that it provided Australian Securities Exchange repurchase program disclosure information as Exhibits 99.1 and 99.2, dated September 1, 2026.
Everus Construction Group, Inc. filed a Form 8-K with the SEC on September 2, 2026, disclosing that the company completed the acquisition of Epsilon Industries, as announced via press release on September 1, 2026.
Starling Oncology, Inc. filed a Form 8-K with the SEC on September 2, 2026, disclosing that board member Brad Hively notified the company on September 1, 2026, of his decision not to stand for re-election at the 2027 annual meeting of stockholders.